INS and dyspepsia: This could represent an advantage regarding two other recently identified inhibitors of mitochondrial pyruvate transport, namely the insulin sensitizers thiazolidinediones33 and the phosphodiesterase inhibitor zaprinast34; the former are known to provoke water retention, increased adiposity and bone loss while headaches, dyspepsia and visual deficits have been reported with the latter.